Faculty

Dean Eliott recieves Lifetime Mentorship Award

Dean Eliott recieves Lifetime Mentorship Award

May 16, 2017

Dean Eliott, MD, received the Lifetime Mentorship Award from the Vit-Buckle Society at their 5th Annual Meeting in April. The Vit-Buckle Society provides an open forum that mentors developing vitreoretinal surgeons, nurtures innovative surgical technologies and therapeutic approaches for retinal diseases, and fosters best practices. This award recognizes a retina specialist who has gone above and beyond training fellows and making a difference in...

Read more about Dean Eliott recieves Lifetime Mentorship Award
john kempen headshot

Systemic therapy outperforms intraocular implant for treating uveitis

May 6, 2017

After seven years, multi-center clinical trial finds systemic therapy better preserves visual acuity and has fewer side effects 

Boston, Mass. — Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better – and had fewer adverse outcomes – than a long-lasting corticosteroid intraocular implant, according to a clinical trial funded by the National Eye Institute (NEI). After seven years, visual acuity on average remained stable among participants on systemic therapy but...

Read more about Systemic therapy outperforms intraocular implant for treating uveitis
reza dana headshot

New technique may prevent graft rejection in high-risk corneal transplant patients

May 1, 2017

Treating donor tissue with a special cocktail of molecules improves outcomes and promotes survival of high-risk corneal transplants

Boston, Mass. — Treating donor corneas with a cocktail of molecules prior to transplanting to a host may improve survival of grafts and, thus, outcomes in high-risk corneal transplant patients, according to a new study led by researchers at Massachusetts Eye and Ear. The findings, ...

Read more about New technique may prevent graft rejection in high-risk corneal transplant patients
Jeremy Wolfe, PhD, named FABBS President

Jeremy Wolfe, PhD, named FABBS President

April 17, 2017

Jeremy Wolfe, PhD, has been named President of the Federation of Associations of Behavioral and Brain Sciences (FABBS). As a coalition of scientific societies, FABBS is eager to advance the sciences of mind, brain, and behavior, and share the contributions of research in these areas with policy makers and the public. He is also serving his second term as a Board Member of the Vision Sciences Society, which is committed to progress in understanding...

Read more about Jeremy Wolfe, PhD, named FABBS President
Researchers identify mechanism of retina damage following chemical eye burns

Researchers identify mechanism of retina damage following chemical eye burns

April 13, 2017

Findings may lead to the development of therapies to prevent damage to the retina, the light-sensitive tissue at the back of the eye.

Boston, Mass. — Chemical eye burns caused by alkali agents not only injure the front of the eye — the cornea, where the contact takes place —  but also cause widespread damage to the light-sensitive tissue at the back of the eye (the retina) as well, often leading to optic nerve damage and glaucoma. In a report...

Read more about Researchers identify mechanism of retina damage following chemical eye burns

Researchers identify new target for abnormal blood vessel growth in the eyes

April 11, 2017

Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease.

Boston, Mass.— A team led by Massachusetts Eye and Ear researchers has identified a novel therapeutic target for retinal neovascularization, or abnormal blood vessel growth in the retina, a hallmark of advanced diabetic eye disease (proliferative diabetic retinopathy).... Read more about Researchers identify new target for abnormal blood vessel growth in the eyes

Jae-Hyun Jung, PhD, receives 2017 Alice J. Adler Fellowship

Jae-Hyun Jung, PhD, receives 2017 Alice J. Adler Fellowship

April 13, 2017

Jae-Hyun Jung, PhD, is the recipient of the 2017 Alice J. Adler Fellowship of the Schepens Eye Research Institute of Mass. Eye and Ear in the amount of $30,000 over one year for his project, “The best field expansion configuration for using multiplexing prism for homonymous hemianopia.” This award is part of the Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine.

Read more about Jae-Hyun Jung, PhD, receives 2017 Alice J. Adler Fellowship
Joan W. Miller

Joan Miller, MD, appointed to AUPO Board of Trustees

April 12, 2017

Joan W. Miller, MD, has been appointed to the Association of University Professors of Ophthalmology (AUPO) Board of Trustees. As Chair of Harvard Ophthalmology since 2003, Dr. Miller is committed driving innovation and quality in academic medicine, and strongly supports mentoring and developing individuals so that they may grow in their leadership positions. According to Dr. Miller, who has attended almost every AUPO meeting since becoming, “AUPO is one of the most...

Read more about Joan Miller, MD, appointed to AUPO Board of Trustees
Growth factor shown to protect the retina in early stage diabetes

Growth factor shown to protect the retina in early stage diabetes

February 3, 2017

New research findings may lead to development of new therapies to delay or prevent the development of diabetic eye disease.

Boston, Mass. — Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear have shown that a slight increase in transforming growth factor beta (TGF-β), which is present in preclinical animal models with diabetic eye disease, protects retinal blood vessels from damage that commonly occurs in the early stages of the disease (known as diabetic retinopathy). Their findings, ...

Read more about Growth factor shown to protect the retina in early stage diabetes

Congratulations to Our 2017 ARVO Fellows!

February 1, 2017

 

The title of ARVO Fellow is an honor established to recognize current ARVO members for their individual accomplishments, leadership and contributions to the Association. ARVO Fellows serve as role models and mentors for individuals pursuing careers in vision and ophthalmology research and help further ARVO's vision, which includes advancing basic and clinical knowledge and serving as the leading international forum for vision research and the primary advocate for vision science worldwide. In 2017, two HMS Ophthalmology faculty members, one former faculty member, and several...

Read more about Congratulations to Our 2017 ARVO Fellows!
Ula Jurkunas

Ula V. Jurkunas, MD, to receive 2017 Carl Camras Translational Research Award

January 31, 2017

Boston, Mass. — Ula V. Jurkunas, MD, Associate Professor of Ophthalmology at Harvard Medical School, Associate Scientist at Schepens Eye Research Institute of Mass. Eye and Ear, and a resident of Winchester, Mass., has been selected to receive a 2017 ARVO Foundation/Pfizer Ophthalmics Carl Camras Translational Research Award. Supported through a donation from Pfizer Ophthalmics, the award includes a $12,000 scholarship in support of Dr....

Read more about Ula V. Jurkunas, MD, to receive 2017 Carl Camras Translational Research Award
Larry Benowitz, PhD

Zinc chelation: A better way to regenerate the optic nerve?

January 30, 2017

 

New research by Larry Benowitz, PhD, and colleagues shows how zinc regulates the survival of retinal ganglion cells, and by binding it (zinc chelation), can help the optic nerve to regenerate. Their findings, published in PNAS (January, 2017), could potentially lead to therapies that help patients with optic nerve injuries due to trauma, glaucoma or other causes, including spinal cord injury....

Read more about Zinc chelation: A better way to regenerate the optic nerve?

Pages